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Microglia are the resident macrophages of the CNS,
and their functions have been extensively studied
in various brain pathologies. The physiological
roles of microglia in brain plasticity and function,
however, remain unclear. To address this ques-
tion, we generated CX3CR1
CreER mice expressing
tamoxifen-inducible Cre recombinase that allow for
specific manipulation of gene function in microglia.
Using CX3CR1
CreER to drive diphtheria toxin receptor
expression in microglia, we found that microglia
could be specifically depleted from the brain upon
diphtheria toxin administration. Mice depleted of
microglia showed deficits in multiple learning tasks
and a significant reduction in motor-learning-depen-
dent synapse formation. Furthermore, Cre-depen-
dent removal of brain-derived neurotrophic factor
(BDNF) from microglia largely recapitulated the
effects of microglia depletion. Microglial BDNF in-
creases neuronal tropomyosin-related kinase recep-
tor B phosphorylation, a key mediator of synaptic
plasticity. Together, our findings reveal thatmicroglia
serve important physiological functions in learning
and memory by promoting learning-related synapse
formation through BDNF signaling.INTRODUCTION
Microglia are a population of resident myeloid cells that occupy
all regions of the mammalian central nervous system (CNS).
Recent studies have shown that microglia colonize the brain1596 Cell 155, 1596–1609, December 19, 2013 ª2013 Elsevier Inc.early during development (embryonic day 9.5) (Ginhoux et al.,
2010). As development proceeds, microglia transition from an
amoeboid to a highly ramified morphology with multiple fine pro-
cesses that display a constant motility within neural tissues
(Davalos et al., 2005; Swinnen et al., 2013). Although the role
of microglia in CNS pathologies has been extensively studied,
their contribution to normal CNS physiology remains unclear.
Disruptions in the colony-stimulating factor 1 (CSF-1) signaling
pathway in mice cause a reduction in the number of microglia,
as well as defects in neuronal structure and function (Michaelson
et al., 1996; Roumier et al., 2004). In humans, mutations inCSF-1
signaling have been associated with presenile dementia
(Paloneva et al., 2000). A variety of structural and functional de-
ficiencies have also been associated with deletion or loss-of-
function mutations in a number of genes expressed in microglia,
including the fractalkine receptor CX3CR1, methyl CpG binding
protein 2 (Mecp2), and homeobox protein HoxB8 (Chen et al.,
2010; Derecki et al., 2012; Paolicelli et al., 2011). Together, these
studies suggest that microglial dysfunction has a significant
detrimental impact on the development and function of the
CNS. However, because genes such as CSF-1, CX3CR1,
Mecp2, and HoxB8 function in many myeloid populations, both
microglia and peripheral myeloid cells were affected in these
studies. Because deficits in peripheral myeloid cells could
have significant effects on the CNS (Dantzer et al., 2008), caution
is warranted in deducing the precise function of microglia in the
brain from experiments using knockout mice that affect both
peripheral and CNS myeloid cells.
Many lines of evidence indicate that experience-dependent
synaptic structural plasticity is important for CNS development,
as well as for learning andmemory formation (Bailey and Kandel,
1993; Grutzendler et al., 2002; Yang et al., 2009a). For example,
motor-skill learning induces the formation of postsynaptic den-
dritic spines in the motor cortex, and the survival of these spines
strongly correlates with performance improvement after learning
(Liston et al., 2013; Yang et al., 2009a). Recent studies have
shown that microglial processes are often in close proximity to
neuronal somata and dendritic spines, and that the dynamics
of microglial processes are regulated by sensory experience
and/or neuronal activity (Tremblay et al., 2010; Wake et al.,
2009). These findings suggest that microglia may play a role in
regulating experience-dependent synaptic plasticity. Recently,
several studies have suggested that microglia are involved in
synaptic pruning through the phagocytosis of synapses during
early postnatal periods, and that this process can be disrupted
by loss of the fractalkine receptor CX3CR1 (Paolicelli et al.,
2011) or complement receptor 3 (CR3/CD11b) (Schafer et al.,
2012). However, synaptic phagocytosis by microglia and synap-
tic pruning defects observed in CX3CR1 and CR3 null mice are
absent during later postnatal development and adulthood (Pao-
licelli et al., 2011; Schafer et al., 2012). Furthermore, similar to
other myeloid genes, CX3CR1 and CR3 have functions not only
in microglia but also in peripheral myeloid populations, which
makes it difficult to pinpoint the precise functions of microglia
using CX3CR1 and CR3 knockout mice. Therefore, it remains
unknown whether and how microglia are involved in experi-
ence-dependent changes of synaptic circuits, particularly in later
postnatal and adult life. It is also unclear whether microglial
dysfunction would contribute significantly to learning deficits
as seen in neurological diseases.
To investigate the precise roles of microglia in the brain, we
generated amouse line that allows specific genetic manipulation
of microglia in an inducible fashion. Here, we report that specific
depletion of microglia leads to deficits in multiple learning tasks
and learning-induced synaptic remodeling. Furthermore, genetic
depletion of brain-derived neurotrophic factor (BDNF) from
microglia recapitulates many of the phenotypes generated by
deletion ofmicroglia, indicating thatmicroglial BDNF is an impor-
tant factor for synaptic remodeling associated with learning and
memory.
RESULTS
Generation of CX3CR1
CreER Mice to Manipulate Gene
Expression in Microglia
In order to manipulate microglial function, we generated
CX3CR1
CreER mice expressing tamoxifen-inducible Cre recom-
binase (CreER) in microglia under the control of the endogenous
CX3CR1 promoter (Figure 1A). The gene encoding CreER was
followed by an IRES-EYFP element and the insertion site was
chosen according to previous studies in which the CX3CR1 cod-
ing region was replaced with enhanced GFP (EGFP) (Jung et al.,
2000). Correct targeting of the CX3CR1 locus and subsequent
flippase (FLP) recombinase-mediated excision of the neomycin
resistance cassette was verified by Southern blot analysis
(Figure 1B). We performed immunostaining for the microglial
marker Iba1 and neuronal marker NeuN in brain slices from
CX3CR1
CreER/+ heterozygous mice. As expected, we found that
virtually all EYFP+ cells (98.8% ± 1.3%, n = 172) were Iba1+,
whereas no NeuN+ cells (n = 401) were EYFP+ (Figure 1C), indi-
cating that the CreER transcript is specifically expressed in mi-
croglia in the brain. To test the functionality of CreER, we crossed
CX3CR1
CreER mice to Rosa26-stop-DsRed reporter allele miceC(R26DsRed) (Luche et al., 2007) to generate CX3CR1
CreER/+:
R26DsRed/+ animals. In the absence of tamoxifen, few DsRed+
microglia (0.3% ± 0.01%) were found in the brain of
CX3CR1
CreER/+:R26DsRed/+ mice (Figure 1D). In contrast, 5 days
after tamoxifen treatment, the majority (93.9% ± 0.5%) of
CX3CR1-EYFP
+ microglia in CX3CR1
CreER/+:R26DsRed/+ mice
were found to coexpress DsRed (Figures 1D and 2A). Thus,
Cre-mediated recombination in microglia is highly efficient in
CX3CR1
CreER/+ mice.
Cre-Dependent Manipulation of Gene Expression in
Microglia
Consistent with previous studies ofCX3CR1 expression patterns
(Jung et al., 2000), enhanced yellow fluorescent protein (EYFP)
expression was also observed in multiple CD11b+ myeloid pop-
ulations in peripheral tissues of CX3CR1
CreER/+ mice (Figure 2A).
We found that the percentages of several myeloid populations
in the brain, blood, and spleen were comparable between wild-
type (WT) mice and CX3CR1
CreER/+ mice at postnatal day 14
(P14) and P30, suggesting that the development and maturation
of myeloid populations, including microglia in the brain, were not
altered in heterozygous CX3CR1
CreER/+mice lacking one copy of
the endogenous CX3CR1 gene (Figures S1A and S1B available
online). As expected, in CX3CR1
CreER/+:R26DsRed/+ mice, Cre-
mediated recombination occurred not only in CNS microglia
but also in CX3CR1
+ cell populations in the spleen (59.0% ±
3.1%), and blood (70.9% ± 4%) 5 days after tamoxifen adminis-
tration (Figures 2A and 2C).
In order to restrict Cre-mediated recombination exclusively to
microglia, we took advantage of the fact that microglia and other
CX3CR1
+ cells have substantially different rates of turnover and
are derived from different precursor populations. Microglia are a
self-renewing population (Ajami et al., 2007) with a low turnover
rate (Lawson et al., 1992), whereas monocytes and inflammatory
macrophages exhibit rapid turnover (van Furth and Cohn, 1968)
and are replenished through a CX3CR1
 bone marrow precursor
population (Fogg et al., 2006). Therefore, upon exposure to
tamoxifen, we expect that microglia would undergo recombina-
tion that persists once tamoxifen has dissipated. Conversely,
peripheral CX3CR1
+ populations would initially undergo recom-
bination but subsequently be replaced by nonrecombined
cells from CX3CR1
 progenitors in the absence of additional
tamoxifen (Figure S1C). Indeed, when CX3CR1
CreER/+:
R26DsRed/+ mice were pulsed with tamoxifen at P1–P3 and
examined 30 days later, 93.0% ± 1.0% of EYFP+ microglia
were found to be DsRed+ (Figures 2A–2C). In contrast, only
7.9% ± 1.9% of cells in the spleen and 1.7% ± 0.5% of the cells
within the blood were DsRed+ (Figures 2A and 2C). These results
demonstrate that CX3CR1
CreER/+ mice, when utilized 30 days
after tamoxifen administration, permit Cre-dependent manipula-
tion of gene expression almost exclusively in microglia.
We next used a similar strategy to express the diphtheria toxin
receptor (DTR) specifically in microglia, and administered
diphtheria toxin (DT) to deplete microglia in the CNS while
leaving other CX3CR1
+ populations intact. To accomplish this,
CX3CR1
CreER mice were crossed with mice harboring the
Rosa26-stop-DTR (R26iDTR) allele (Buch et al., 2005), and
CX3CR1
CreER/+:R26iDTR/+ mice were given tamoxifen 30 daysell 155, 1596–1609, December 19, 2013 ª2013 Elsevier Inc. 1597
α-EYFP Iba1 -Tamox +Tamox
A
D
B
W
T Ta
rge
ted
Ne
o d
ele
ted
17 kb
11 kb
9 kb
Merge
C
CX3CR1 exon 2
CreER-IRES-EYFP Neor
CreER-IRES-EYFP
Af
lII
Af
lII
Af
lII
Af
lII
Af
lII
Af
lII
Af
lII
Af
lII
Targeting Vector
WT CX3CR1 allele
Targeted 
CX3CR1
CreER allele
Neor deleted 
CX3CR1
CreER allele
CreER-IRES-EYFP Neor
Af
lII
FRT FRT
FRT FRT
FRT
3’ Probe
ATG
3’ Probe
3’ Probe
5’ Probe
5’ Probe
5’ Probe
1.2 kb 8 kb
3’ UTR
17 kb
11 kb
9 kb
TK
NeuN
3028P26
Ta
mo
x/M
oc
k
An
aly
sis
α
-E
Y
FP
α
-D
sR
ed
M
er
ge
CX3CR1CreER/+:R26DsRed/+CX3CR1CreER/+
Figure 1. Generation of Mice Carrying the CX3CR1
CreER Allele
(A) Schematic of the targeting strategy used for knockin of CreER-IRES-YFP at the CX3CR1 locus.
(B) Southern blot analysis of AflII digested genomic DNA from untargeted (WT), CX3CR1
CreER-targeted, or CX3CR1
CreER mice after deletion of the neomycin
resistance sequence.
(C) Coronal sections of motor cortex from P45 CX3CR1
CreER mice stained for EYFP, Iba1, and NeuN.
(D) Coronal sections of motor cortex from mice of the indicated genotypes and treatments (scale bar, 100 mm).prior to the administration of DT (Figure 2D). We found that
CX3CR1
CreER/+:R26iDTR/+ mice had a marked (99.1% ± 0.8%)
reduction of CNS microglia within 1 day after administration
of DT (Figures 2E–2G). In contrast, the number of microglia
was not affected in the brain of control mice carrying a single
copy of theCX3CR1
CreER allele only. Seven days after DT admin-
istration, the number of microglia remained significantly lower
(84.8% ± 3.0% reduction) in CX3CR1
CreER/+:R26iDTR/+ mice
than in control mice (Figures 2E and 2G), suggesting limited
repopulation of microglia within 1 week of depletion. Impor-
tantly, we observed no significant difference in the number of1598 Cell 155, 1596–1609, December 19, 2013 ª2013 Elsevier Inc.CX3CR1
+ CD11b+ cells in the spleen or blood between
CX3CR1
CreER/+:R26iDTR/+ mice and control mice (Figures 2H
and 2I). These experiments demonstrate that CX3CR1
CreER/+:
R26iDTR/+ mice can be used to specifically and robustly delete
microglia in the CNS.
Within the first week aftermicroglial depletion, we found no dif-
ference in animal viability (n = 14–16 per group) or weight change
(Figure S2A) between microglia-depleted and nondepleted con-
trol mice. To investigate whether microglial ablation may cause
inflammatory responses in the CNS, we measured transcript
and protein levels of the inflammatory cytokines tumor necrosis
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Figure 2. A Strategy to Restrict Cre-Mediated Manipulation of Gene Function, Including Deletion of Microglia
(A) CX3CR1-EYFP
+ CD11b+ populations in various tissues from mice of the indicated genotypes 5 or 30 days after tamoxifen treatment.
(B) Coronal sections of motor cortex from CX3CR1
CreER/+:R26DsRed/+ mice stained for EYFP and DsRed 30 days after tamoxifen treatment.
(C) Quantification of flow-cytometry fluorescence-activated cell sorting (FACS) analysis showing the percentage of CX3CR1-EYFP
+ cells coexpressing DsRed in
multiple tissues at 5 or 30 days after tamoxifen treatment.
(D) Time course of tamoxifen/DT administration and analysis.
(E) FACS analysis of microglia in the brain of control and microglia-depleted mice at the indicated time points after DT administration. Dot plots show the total
number of CX3CR1-EYFP
+ CD11b+ cells gated on DAPI CD3 CD19 CD45int.
(F) Coronal sections of motor cortex from control or microglia-depleted mice stained for Iba1 1 day after DT administration.
(G) Number of CX3CR1-EYFP
+ CD11b+ microglia in the brain after DT administration at various time points.
(H) FACS analysis showing the percentage of CX3CR1-EYFP
+ CD11b+ cells in the spleen and blood of mice after DT administration.
(I) Quantification of data shown in (H). n = 4 animals for each experimental condition. Data are represented as mean ± SEM. ****p < 0.0001, *p < 0.05. Scale bar,
100 mm.
See also Figures S1, S2, and S3.factor a (TNFa), interleukin-1b (IL-1b), and IL-6 in brain tissues,
and observed no significant difference between the microglia-
depleted and control mice (Figures S2B–S2D). We also found
no significant difference in the immunostaining of glial fibrillary
acidic protein (GFAP) and glutamate transporter GLT-1 within
7 days after microglial depletion in either the motor cortex or hip-
pocampal CA1 region (Figures S2E–S2J). In addition, we found
no alterations in blood-brain-barrier permeability betweenmicro-
glia-depleted and control mice as measured by the amount of
Evans Blue dye in the brain after intravenous injection (Fig-
ure S2K). To determine whether depletion of microglia altered
the overall densities of neurons and synapses, we stained sec-
tions of the motor cortex and hippocampal CA1 region for
NeuN, cleaved caspase 3 (CC3), or the presynaptic marker
synaptic vesicle protein 2 (SV2) and found no significant differ-
ence in these parameters between microglia-depleted andCcontrol mice (Figure S3). Taken together, these findings suggest
that depleting microglia leaves surrounding brain tissues mini-
mally disturbed. Thus, CX3CR1
CreER/+:R26iDTR mice provide an
important tool to delete microglia and examine their function in
the CNS.
Depletion of Microglia Reduces Synaptic Structural
Plasticity Associated with Learning
Recent studies have suggested that microglia participate in syn-
apse elimination through a phagocytic engulfment mechanism
involving the fractalkine receptor CX3CR1 (Paolicelli et al.,
2011) or complement receptor 3 (CR3/CD11b) (Schafer et al.,
2012). This process of synaptic phagocytosis seems to occur
only during early, and not late, postnatal periods (Paolicelli
et al., 2011; Schafer et al., 2012). To determine the potential
function of microglia in the mature brain, we first investigatedell 155, 1596–1609, December 19, 2013 ª2013 Elsevier Inc. 1599
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Figure 3. Microglia Are Important for
Learning-Dependent Spine Remodeling
and Performance Improvement
(A) Timeline of tamoxifen/DT administration and
in vivo imaging in CX3CR1-iDTR mice.
(B) Transcranial two-photon imaging of dendritic
spines in control and microglia-depleted mice.
Filled and empty arrowheads indicate spines
formed or eliminated between two views. Asterisk
indicates filopodia.
(C and D) The percentage of spines that were
formed or eliminated within 4 days in the motor
cortex was significantly reduced after microglia
depletion in both P19 (C) and P30 animals (*p <
0.05, **p < 0.01, n = 4–6).
(E) Timeline of tamoxifen/DT administration,
rotarod training, and in vivo imaging.
(F) Motor-learning-related spine remodeling was
significantly reduced in P30 mice with microglia
depletion (*p < 0.05, **p < 0.01, n = 4–5).
(G) Motor-learning-related spine formation was
significantly reduced in P60 mice with microglia
depletion (**p < 0.01, n = 4–5).
(H) Average speed reached during the first rotarod
training session in P30 mice (n = 6–7).
(I) Average speed reached during the first rotarod
training session in P60 mice (n = 8).
(J) Microglia-depleted mice showed impaired
performance improvement compared with non-
depleted control mice over 1 or 2 days of training
(*p < 0.05, n = 6–7).
(K) P60 microglia-depleted mice showed impaired
performance improvement compared with non-
depleted control mice over 1 or 2 days of training
(*p < 0.05, n = 8).
(L) Percentage of freezing in control or microglia-
depleted mice before (pre-CS) and during (CS)
presentation of the conditioned stimulus in the
recall test (*p < 0.05, n = 8).
(M) The discrimination ratio of time spent inter-
acting with a novel object versus a familiar object
in a NOR assay was significantly altered in mi-
croglia-depleted mice (*p < 0.05, n = 8). Data are
represented as mean ± SEM.
See also Figure S4.whether microglia depletion might alter synaptic structural plas-
ticity during the late postnatal period (P19) or young adulthood
(P30). Using transcranial two-photon microscopy (Yang et al.,
2009a), we examined the effect of microglial depletion on the
baseline remodeling of postsynaptic dendritic spines of layer V
pyramidal neurons in the motor cortex of Thy1 YFP-H line mice
crossed with CX3CR1
CreER/+ or CX3CR1
CreER/+:R26iDTR/+ mice
(Figures 3A and 3B). We found that at either P19 or P30,
microglial depletion caused a significant decrease in both spine
formation and elimination over 4 days (Figures 3C and 3D). In
addition, we observed that baseline spine remodeling was not
altered in CX3CR1
CreER/+ mice lacking a single copy of the
endogenous CX3CR1 gene, as CX3CR1
CreER/+:Thy1 YFP-H and
CX3CR1
+/+:Thy1 YFP-H mice showed similar rates of spine
turnover (Figure S4A). Taken together, these findings suggest
that microglia are involved in not only spine elimination but1600 Cell 155, 1596–1609, December 19, 2013 ª2013 Elsevier Inc.also spine formation during late postnatal development and
young adulthood.
Previous studies have shown that motor-skill learning causes
an increase in dendritic spine remodeling in the motor cortex,
and that the degree of new spine formation correlates with per-
formance improvement after learning (Liston et al., 2013; Yang
et al., 2009a). To investigate the role of microglia in this process,
we examined whether depletion of microglia altered spine for-
mation and elimination over 4 days in response to rotarod motor
learning (Figure 3E). We found a significant decrease in learning-
dependent formation and elimination of dendritic spines in
1-month-old microglia-depleted mice as compared with age-
matched controls (Figure 3F). Furthermore, in 2-month-old adult
mice, microglia depletion caused a significant decrease in
learning-dependent spine formation, but not spine elimination
(Figure 3G). Notably, although the baseline performance of
microglia-depleted animals remained unchanged (Figures 3H
and 3I), there was a significant decrease in performance
improvement after motor learning in microglia-depleted mice
as compared with control mice at P30 and P60 (Figures 3J,
3K, and S4B). These results demonstrate that microglia have
an important role in learning-induced remodeling of excitatory
synapses, as well as in animals’ performance improvement after
motor learning.
To further understand the effect of microglia deletion on
learning and memory, we compared microglia-depleted and
control mice in two additional behavioral paradigms: auditory-
cued fear conditioning (FC) and novel object recognition
(NOR). We found that microglia-depleted animals exhibited
significantly reduced freezing fear response to the auditory cue
during the recall test as compared with nondepleted controls
(Figure 3L). Additionally, whereas the nondepleted control mice
showed a preference toward the novel object during the NOR
test, the microglia-depleted mice showed no such preference
(Figure 3M). Thus, mice lacking microglia demonstrate deficits
in multiple behavioral tasks, underscoring an important role of
microglia in learning and memory that involves multiple brain
regions.
Depletion of Microglia Alters Synaptic Protein Levels
and Glutamatergic Synaptic Function
Our results indicate that microglial depletion causes defects in
learning-induced dendritic spine remodeling and behavioral
performance. To better understand synaptic alterations after mi-
croglial deletion, we examined the levels of various proteins in
microglia-depleted brain, focusing on those involved in synaptic
plasticity and function. We first performed a quantitative proteo-
mic screen from whole-brain protein extracts by shotgun multi-
dimensional liquid chromatography–tandemmass spectrometry
(LCLC-MS/MS) high-resolution mass spectrometric proteome
analysis (Washburn et al., 2001). Specifically, we utilized 15N-
labeled mouse brains as an internal standard and mixed 15N
whole brain 1:1 with P30 microglia-depleted or control littermate
brains to calculate relative protein profiles (Figure 4A). A similar
approach was used previously for proteome-wide quantitative
analysis of long-lived proteins and synaptosome changes during
development (Savas et al., 2012). We quantified a total of 6,562
proteins and found that the levels of 61 proteins were signifi-
cantly altered as a result of microglia depletion (Figure 4B; Table
S1; ANOVA p value < 0.05, log2 fold change R 20%). Impor-
tantly, 21/61 (34%) of the significantly altered proteins had
known roles in synaptic plasticity/function, such as the postsyn-
aptic glutamate (NMDA) receptor subunit epsilon-2 (GluN2B)
and the presynaptic vesicular glutamate transporter 1 (VGlut1).
We additionally found the glutamate (AMPA) receptor subunit 2
(GluA2) to be decreased, although it did not meet our signifi-
cance criteria.
To further investigate the alteration of synaptic proteins after
microglia depletion, we generated synaptosome fractions from
microglia-depleted mice and compared them with those from
the nondepleted controls. In line with the results of our proteo-
mic screen, we found VGlut1 and GluA2 to be significantly
decreased in synaptosomes from microglia-depleted brains.
Although GluN2B protein was increased in the whole-brainCfraction as shown in our proteomic screen, its level was
decreased in the synaptosome fraction, suggesting differential
alteration of GluN2B in synaptosome versus nonsynaptosome
fractions after microglial depletion. The NMDAR subunit
GluN2A and the AMPAR subunit GluA1 remained unaltered be-
tween microglia-depleted mice and controls (Figures 4C and
4D). These results support the data from our proteomic screen
and demonstrate that microglia-depleted brains display signifi-
cant and specific changes of synaptic proteins at glutamatergic
synapses.
To test whether changes in the abundance of the synaptic
proteins GluN2B, VGlut1, and GluA2 after microglia depletion
affect glutamatergic synaptic function, we performed whole-
cell patch-clamp recordings from layer V pyramidal neurons in
the motor cortex of P30 mice 1 day after the depletion of micro-
glia. We found that the frequencies of both NMDA and AMPA
receptor-mediated miniature excitatory postsynaptic currents
(mEPSCs) were significantly decreased as compared with con-
trols (Figures 4E–4H), suggesting a decrease in spontaneous
glutamate release in the absence of microglia. Furthermore,
the decay time of NMDA mEPSCs, but not AMPA mEPSCs,
was significantly reduced in microglia-depleted animals,
whereas the amplitude of spontaneous NMDA and AMPA
mEPSCs remained unchanged (Figures 4F and 4H). The
decrease in the decay time of NMDA mEPSCs is consistent
with the reduction of GluN2B subunits in microglia-depleted
mice, as GluN2A-dominant NMDA receptors have faster decay
times (Chen et al., 1999). Taken together, these data indicate
that microglia play a role in regulating the level of several synap-
tic proteins that are important for the function of glutamatergic
excitatory synapses in the brain.
Removal of BDNF from Microglia Reduces Learning-
Dependent Synaptic Structural Plasticity
The above results show that microglia deletion causes a reduc-
tion in several synaptic proteins involved in synaptic plasticity
and function. However, the molecular mechanisms underlying
the interaction between microglia and neurons remain unknown.
To address this question, we investigated the role of brain-
derived neurotrophic factor (BDNF) in mediating microglial-
neuron interactions. We choose to study microglial BDNF for
two reasons: First, BDNF exists in many cell types, including mi-
croglia, and BDNF from microglia has been shown to modulate
neuronal plasticity in a mouse model of neuropathic pain (Coull
et al., 2005). Second, BDNF is a potent regulator of synaptic
development and plasticity (Chao, 2003), and increases den-
dritic spine plasticity in the adult cortex (Chakravarthy et al.,
2006), GluN2B activation (Levine et al., 1998), and the level of
VGlut1 (Melo et al., 2013). Given our findings that microglia
depletion causes a reduction of GluN2B and VGlut1 as well as
dendritic spine plasticity, it is possible that a lack of microglial
BDNF may underlie some of the phenotypes associated
with microglia depletion. To test this possibility, we crossed
CX3CR1
CreER mice with mice containing a floxed allele of
BDNF (BDNFflox) (Rios et al., 2001) to remove BDNF from micro-
glia. We first validated this approach by sorting CX3CR1-EYFP

cells or CX3CR1-EYFP
+ microglia from the brains of
CX3CR1
CreER/+:BDNFfl/+ (BDNFfl/+), or CX3CR1
CreER/+:BDNFfl/flell 155, 1596–1609, December 19, 2013 ª2013 Elsevier Inc. 1601
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Figure 4. Biochemical and Electrophysiological Properties of Synapses Are Altered in Microglia-Depleted Brains
(A) Quantitative proteomic scheme to identify CNS proteins altered after microglial depletion. Control (n = 3) or microglia-depleted (n = 3) brain homogenates were
mixed 1:1 with 15N internal standard and prepared together. Samples were then analyzed by LCLC-MS/MS shotgun proteomics. Green dots represent microglia.
(B) Proteomic summary volcano plot (x axis = log2 CX3CR1
CreER/+/CX3CR1
CreER/+:R26iDTR/+; y axis = log10 ANOVA p value). Black open circles: quantified
proteins; red open circles: significantly altered proteins; green filled circles: significantly altered proteins with known synaptic functions.
(C) Synaptosome fractions from control or microglia-depleted brains probed with indicated antibodies by western blot.
(D) Densitometric quantification of western blots in (C) (*p < 0.05, n = 6).
(E) Examples of NMDA mEPSCs in layer V pyramidal neurons from control and microglia-depleted mice.
(F) Average NMDAmEPSC frequency, amplitude, and decay time in control (n = 17 cells) andmicroglia-depletedmice (n = 17 cells). mEPSC frequency and decay
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See also Table S1.
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(BDNFfl/fl) mice that had been given tamoxifen (Figure S5A) and
assayed for recombination of the conditional BDNF allele using
a PCR-based strategy. As expected, no recombination was
observed in CX3CR1-EYFP
 cells. In contrast, robust recombi-
nation of the floxed allele was observed in CX3CR1-EYFP
+
microglia from BDNFfl/+ or BDNFfl/fl mice (Figure 5A). After
administration of tamoxifen, the level ofBDNFmRNA inmicroglia
from CX3CR1
CreER/+:BDNFfl/fl mice was markedly reduced as
compared with CX3CR1
CreER/+:BDNFfl/+ controls (Figure 5B).
Interestingly, the overall levels of BDNF protein in the cortex
and hippocampus of CX3CR1
CreER/+:BDNFfl/fl mice were un-
changed compared with CX3CR1
CreER/+:BDNFfl/+ controls (Fig-
ure 5C). Taken together, these results indicate that BDNF can
be specifically removed from microglia without causing a signif-
icant alteration in the total level of BDNF protein in the cortex or
hippocampus.
To investigate the potential impact of microglial BDNF
removal, we first stained the motor cortex and hippocampal
CA1 region for NeuN, cleaved caspase 3, or SV2 but found no
significant difference in these parameters between microglial
BDNF-deleted and control mice (Figures S5B–S5D). Thus,
microglial BDNF removal does not alter the overall densities of
neurons or synapses in the cortex or hippocampus. We next
asked whether removal of BDNF from microglia had any effects
on the level of synaptic protein expression, motor-learning-
induced synaptic plasticity, and performance improvement after
learning. We performed western blot analysis of synaptosomes
and found a significant decrease in the levels of GluN2B and
VGlut1, but not GluA2, in mice lacking microglial BDNF
(BDNFfl/fl) as compared with control mice (BDNFfl/+) (Figures
5D and 5E). Importantly, BDNF removal from microglia resulted
in a significant decrease in motor-learning-induced spine for-
mation, but not spine elimination, over 2 days (Figures 5F and
5G). Furthermore, similar to what was observed for microglia-
depleted animals, whereas BDNF removal from microglia had
no effect on baseline rotarod performance, mice lacking micro-
glial BDNF demonstrated a reduction in performance improve-
ment after motor training as compared to controls (Figures 5H
and 5I). Mice lacking microglial BDNF also showed significantly
reduced freezing fear response to the conditioned auditory cue
stimulus during the recall test (Figure 5J). In the NOR task, how-
ever, mice lacking microglial BDNF did not show a significant
difference from the control mice (Figure 5K). Taken together,
these results demonstrate that loss of microglial BDNF
recapitulates several defects observed in microglia-depleted
mice and suggest that microglial BDNF is an important regu-
lator of learning-induced synaptic formation and behavioral
performance.
Microglial BDNF Affects Synaptic Plasticity via the
Tropomyosin-Related Kinase Receptor B Signaling
Pathway
As microglial processes are located in close proximity to synap-
ses, microglial BDNF could be released to directly affect the
structure and function of nearby synapses. Alternatively, micro-
glial BDNF could have a role in microglial differentiation or
homeostasis, and the removal of BDNF from microglia might
act in an autocrine fashion and indirectly affect synapticCplasticity. To distinguish between these possibilities, we first
compared the overall number, rate of proliferation, and tissue
distribution of microglia between CX3CR1
CreER/+:BDNFfl/fl and
CX3CR1
CreER/+:BDNFfl/+ controls, but found no significant
differences in any of these parameters (Figures S6A–S6E). To
examine whether loss of microglial BDNF might alter the associ-
ation of microglial processes with dendritic spines, wemeasured
the percentage of spines of layer V pyramidal neurons in the
motor cortex that had Iba1+ microglial processes within 1 mm
and found no significant difference between CX3CR1
CreER/+:
BDNFfl/fl and CX3CR1
CreER/+:BDNFfl/+ control mice (Figures
S6F and S6G). These results demonstrate that loss of BDNF
from microglia does not alter the number, proliferation, or distri-
bution of microglia, or the spatial association of microglial pro-
cesses with dendritic spines.
The above findings suggest that microglial BDNF may be
released to directly affect the plasticity of nearby synapses.
BDNF is produced within neurons as a propeptide (proBDNF)
that is subsequently cleaved to generate mature BDNF
(mBDNF). Because the pro and mature forms of BDNF bind
different receptors on the surface of neurons (p75/sortilin and
tropomyosin-related kinase receptor B [TrkB], respectively) to
affect different cellular processes (Chao, 2003), we asked
whether, and in which form, BDNF might be produced and
secreted by microglia. Because endogenous BDNF protein is
difficult to detect due to low abundance (Herzog et al., 1994),
we utilized BDNF-hemagglutinin knockin mice (BDNF-HA) in
which the BDNF gene is replaced by HA-tagged BDNF (Yang
et al., 2009b). We generated purified cultures of hippocampal
neurons or microglia from P1 BDNF-HA/HAmice (microglial pu-
rity 98.6% ± 0.1%; Figure S6H) and immunoprecipitated HA-
tagged BDNF from either the cell lysates or culture media of
both cell types. In agreement with previous results, significant
quantities of both proBDNF and mBDNF could be detected in
both cell lysates and culture media from BDNF-HA neurons.
Notably, both forms of BDNF were also detected in cell lysates
and culture media from pure microglia cultures although the dis-
tribution of pro-BDNF to mBDNF in microglial lysates appeared
to be weighted toward themature form (Figure 6A). These results
demonstrate that microglia are capable of producing and
secreting both pro-BDNF and mBDNF.
It is well established thatmature BDNF binds to TrkB receptors
located on neurons, and binding of mBDNF to TrkB triggers a
signaling cascade that promotes autophosphorylation of TrkB
and synaptic plasticity (Chao, 2003). Consistent with an interac-
tion between microglia BDNF and TrkB receptors, western blot
analysis of synaptosomes showed a significant decrease in
the levels of phosphorylated TrkB (p-TrkB) in CX3CR1
CreER/+:
BDNFfl/flmice lacking microglial BDNF as compared with control
CX3CR1
CreER/+:BDNFfl/+ mice (Figure 6B). To investigate micro-
glia BDNF and TrkB signaling further, we tested the ability of the
media from cultures of purified microglia (microglia-conditioned
media [MCM]) from CX3CR1
CreER/+:BDNF+/+ or CX3CR1
CreER/+:
BDNFflox/floxP1mice to phosphorylate TrkB in cultures of purified
cortical neurons. Within 30 min, MCM from CX3CR1
CreER/+:
BDNF+/+ mice was able to significantly increase the phosphory-
lation of TrkB compared with baseline levels in untreated
neuronal cultures. Importantly, MCM generated from microglialell 155, 1596–1609, December 19, 2013 ª2013 Elsevier Inc. 1603
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Figure 5. Loss of Microglial BDNF Results in Altered Synaptic Protein Levels, Synaptic Structural Plasticity, and Performance Improvement
after Learning
(A) PCR-based analysis of WT (BDNFWT), conditional undeleted (BDNFflox), and conditional deleted (BDNFD) BDNF alleles from CX3CR1-EYFP
 and CX3CR1-
EYFP+ cells sorted from the CNS of CX3CR1
CreER/+:BDNFflox/+ or CX3CR1
CreER/+:BDNFflox/flox after tamoxifen treatment.
(B) Quantitative real-time PCR analysis of BDNF mRNA isolated from CX3CR1-EYFP
+ microglia purified from BDNFflox/+ or BDNFflox/flox mice (**p < 0.01, n = 3).
(C) Average protein levels of total BDNF in the cortex or hippocampus of CX3CR1
CreER/+:BDNFflox/+ or CX3CR1
CreER/+:BDNFflox/flox mice as measured by ELISA
(n = 4).
(legend continued on next page)
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Figure 6. Microglia Produce Both Pro-BDNF and mBDNF to Phosphorylate Neuronal TrkB
(A) Neurons or microglia were cultured from P1mice from BDNF-HA orWT animals. Cell lysates or culture media were immunoprecipitated with a rabbit antibody
to HA. Pro-BDNF and mBDNF were detected by immunoblotting with a second antibody to HA (mouse HA1.1).
(B) Synaptosome westerns for p-TrkB from CX3CR1
CreER/+:BDNFflox/+ or CX3CR1
CreER/+:BDNFflox/flox mice (*p < 0.05, n = 6).
(C) Representative immunoblots of E18 rat neurons at 8 days in vitro, treated as indicated.
(D) Densitometric quantification of p-TrkB western blots in (C) (*p < 0.05, **p < 0.005, n = 9). Data are represented as mean ± SEM.
See also Figure S6.cultures devoid of BDNF (Figure S6I) failed to increase the phos-
phorylation of TrkB (Figures 6C and 6D). Previous studies
demonstrated that ATP acting through the purinergic receptor
P2X4 is able to increase both the synthesis and release of
BDNF from microglia in vitro (Trang et al., 2009). To test whether
ATP and/or P2X4R are also involved in the ability of MCM to
phosphorylate TrkB, we treated purified cultures of microglia
with ATP or with ATP and the P2X4R antagonist 2
0,30-O-(2,4,6-tri-
nitrophenyl)-ATP (TNP-ATP) before harvesting MCM. Pretreat-
ment of microglia cultures with ATP significantly increased the(D) Synaptosome fractions from the brains of CX3CR1
CreER/+:BDNFflox/+ or CX3C
(E) Densitometric quantification of western blots in (D) (*p < 0.05, n = 6).
(F) Transcranial two-photon imaging of dendritic spines in Thy1 YFP mice crosse
after rotarod training. Filled and empty arrowheads indicate spines that were form
Scale bar, 2 mm.
(G) Percentage of existing spines that were eliminated or new spines that formed
(***p < 0.001, n = 4).
(H) Average speed reached during the first rotarod training session (n = 5–7).
(I) Performance increase in motor-learning task over 1 or 2 days of rotarod traini
(J) Percentage of freezing in control CX3CR1
CreER/+:BDNFflox/+ and CX3CR1
Cr
conditioned stimulus in the recall test (*p < 0.05, n = 6–7).
(K) The discrimination ratio of time spent interacting with a novel object versus
microglial BDNF (*p < 0.05, n = 8). Data are represented as mean ± SEM.
See also Figure S5.
Cability of MCM to phosphorylate TrkB, and this increase was
blocked by the addition of TNP-ATP to the cultures (Figures 6C
and 6D). Taken together, these findings suggest that microglial
BDNF promotes synaptic structural plasticity involving activation
of TrkB signaling.
DISCUSSION
The lack of tools to specifically perturb microglia at defined time
points in a living animal has made it difficult to delineate theR1CreER/+:BDNFflox/flox mice probed with indicated antibodies.
d with CX3CR1
CreER/+:BDNFflox/+ or CX3CR1
CreER/+:BDNFflox/flox mice before or
ed or eliminated, respectively, between two views. Asterisk indicates filopodia.
over 2 days of training in the motor cortex of BDNFflox/+ or BDNFflox/flox mice
ng (*p < 0.05; error bars, SEM; n = 5–7).
eER/+:BDNFflox/flox mice before (pre-CS) and during (CS) presentation of the
a familiar object in a NOR assay was significantly altered in mice depleted of
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precise functions of microglia in the physiological brain. In this
work, we have generated a tool that allows the specific and
inducible manipulation of microglial numbers and functions
within the CNS. Using this tool, we have revealed a physiological
role of microglia in learning and learning-associated synaptic
structural remodeling. Moreover, the use of CX3CR1
CreER mice
allowed us to uncover an important role of microglial BDNF in
these processes.
Interactions betweenMicroglia and Neurons: Promoting
Learning-Induced Synapse Formation
Microglial processes are constantly motile in the physiological
brain and are found in close proximity to synapses in both the
early postnatal and adult cortex (Davalos et al., 2005; Tremblay
et al., 2010; Wake et al., 2009). The functional outcome of micro-
glial interaction with neurons appears to depend on the develop-
mental stage of the CNS. In the embryonic brain, which has high
levels of programmed neuronal cell death, microglia have been
observed to phagocytose apoptotic neurons (Peri and Nu¨s-
slein-Volhard, 2008) or actively participate in the killing of neu-
rons (Marı´n-Teva et al., 2004). In the embryonic zebrafish optic
tectum, microglia appear to play a role in the homeostasis of
neuronal activity by silencing neurons through a contact-depen-
dent mechanism (Li et al., 2012). Recent work has shown that
mice lackingCX3CR1 have delayed invasion of the cortical barrel
fields by microglia, and a transient delay in the normally
observed AMPA receptor subunit switching in thalamocortical
barrel cortex synapses (Hoshiko et al., 2012). Furthermore, it
was recently proposed that microglia are involved in the active
engulfment of synapses in the hippocampus and the dorsal
lateral geniculate nucleus (dLGN) during early postnatal develop-
ment (Paolicelli et al., 2011; Schafer et al., 2012). Pruning of syn-
apses within the dLGN is thought to depend upon the presence
ofCR3, which may interact with synaptically localized C3 protein
that acts as a positive signal for phagocytosis of presynaptic
axonal terminals.
By taking advantage of CX3CR1
CreER mice and transcranial
two-photon imaging, we observed a significant decrease in
learning-induced formation of postsynaptic dendritic spines in
the absence ofmicroglia ormicroglial BDNF in young andmature
adult mice. Two lines of evidence suggest that the main synaptic
function of microglia in the mature brain is the promotion of den-
dritic spine formation rather than spine elimination. First, removal
of BDNF from microglia causes a significant decrease in
learning-induced spine formation, but not spine elimination,
over 2 days. Second, previous studies have shown that motor-
learning-induced spine formation occurs 2 days before spine
elimination, and that the degrees of spine formation and elimina-
tion are strongly correlated (Liston et al., 2013; Yang et al.,
2009a). Therefore, the decreased spine elimination observed in
the absence of microglia may simply be a result of fewer spines
being formed after motor learning. It is worth noting that we also
observed a decrease in spine formation and elimination at P19.
This raises the possibility that microglia have an important
function in promoting synapse formation not only during the
late postnatal stage and adulthood but also during the early
postnatal period (e.g., the first postnatal week), when both
synaptogenesis and pruning are extensive.1606 Cell 155, 1596–1609, December 19, 2013 ª2013 Elsevier Inc.Previous studies have shown that learning-dependent syn-
apse formation strongly correlates with performance improve-
ment after learning (Liston et al., 2013; Yang et al., 2009a).
Concomitantly with the reduction of learning-induced spine for-
mation, we observed a significant decrease in performance
improvement after rotarod learning in the absence of microglia
or microglial BDNF. Additionally, we found that microglia have
important roles in fear learning and NOR tasks. These results un-
derscore the important function of microglia in forming structural
correlates of learning experiences that are critical for behavioral
performance. These findings also suggest that microglial dys-
functions may cause a reduction of learning-dependent synaptic
formation and contribute to learning deficits in neurological dis-
eases. Furthermore, because activation of microglia is common
in many neurodegenerative diseases and accompanies alter-
ations of gene expression, microglia activation may compromise
the physiological function of microglia and contribute to the dis-
ease pathophysiology. Future use of CX3CR1
CreER mice to acti-
vate and inactivate important signaling pathways inmicroglia will
aid in addressing these questions.
The Role of Microglial BDNF in Synaptic Plasticity and
Function
The neurotrophin BDNF is a critical mediator of neuronal survival,
differentiation, and plasticity (Chao, 2003). Although the major
source of BDNF in the adult brain appears to be neurons (Raus-
kolb et al., 2010), BDNF can also be detected in oligodendro-
cytes, astrocytes, and microglia (Dougherty et al., 2000).
Through conditional gene inactivation, we have determined
that microglial BDNF also plays an important role in the healthy
brain by regulating learning-induced synapse formation. Our
results showing that the overall levels of BDNF protein do not
change in the absence of microglial BDNF are in agreement
with previous findings that small changes in BDNF levels or the
presence of a SNP in the BDNF gene could have significant
neurological effects (Greenberg et al., 2009). Because microglial
processes are highly motile and located in close proximity to
synaptic terminals (Davalos et al., 2005; Tremblay et al., 2010;
Wake et al., 2009), our data raise the possibility that the release
of BDNF from microglia may be regulated in a localized and/or
activity-dependent fashion. Indeed, themajority of BDNF release
by neurons in the adult brain appears to be triggered by neuronal
activity (Balkowiec and Katz, 2000). It is attractive to speculate
that BDNFmay be secreted frommicroglial processes to specif-
ically modulate a subset of synaptic connections involved in a
particular learning task.
Through what mechanisms does microglial BDNF exert its
effects on the CNS? Our results suggest that similar to neuronal
BDNF, microglial BDNF could act on neuronal TrkB and modu-
late glutamatergic synaptic transmission and plasticity (Rex
et al., 2007).Microglial BDNF could also affect inhibitory synaptic
transmission via TrkB signaling, as has been shown in the spinal
cord (Coull et al., 2005) and hippocampus (Zheng et al., 2011). In
addition, the microglia themselves express activated TrkB, and
BDNF released from microglia has been shown to increase
their proliferation (Spencer-Segal et al., 2011). Although we are
unable to detect changes in the number or spatial distribution
of microglia in mice lacking microglial BDNF, it would be
interesting to investigate whether microglial BDNF may act in an
autocrine manner to influence microglial function. An equally
interesting area for further investigation is the signals that trigger
BDNF release from microglia within the cortex. Several lines of
evidence suggest that a major stimulus for BDNF release from
microglia is the binding of ATP to the purinergic receptor
P2X4R. Because ATP is released at sites of active synaptic trans-
mission (Khakh and North, 2012) and acts as a robust chemoat-
tractant for microglial processes (Davalos et al., 2005), one
intriguing possibility is that ATP recruits microglial processes to
active synapses where they subsequently release BDNF. Our
in vitro experiments suggest that P2X4 receptors could play an
important role in promoting BDNF release and TrkB phosphory-
lation. However, it remains to be determined whether the basal
level of P2X4 receptors is sufficient to promote BDNF release
in the normal CNS, or whether other factors also contribute.
Lastly, microglia may modulate synaptic functions in the healthy
CNS that are independent of BDNF. Our proteomics screen
identified numerous proteins with known synaptic functions
that were altered in the absence of microglia (Table S1). Future
studies using CX3CR1
CreER mice are required to better under-
stand how microglia impact synaptic plasticity and function via
BDNF and other signaling pathways in both the developing
and adult brain.
EXPERIMENTAL PROCEDURES
Mice
All mice were maintained in the Skirball Institute specific pathogen-free animal
facility and handled in accordance with the institutional guidelines for animal
care and use. Detailed information on the various mouse strains used is
provided in the Extended Experimental Procedures.
Isolation of Tissues and Flow Cytometry
Single-cell suspensions were generated from harvested organs, stained, and
analyzed by polychromatic flow cytometry.
Histology, Quantitative RT-PCR, and ELISA
These standard experiments were performed with commercially available
kits and reagents. See the Extended Experimental Procedures for more
information.
Mass Spectrometry
Mass spectrometry sample processing and analysis was performed as previ-
ously reported (Butko et al., 2013), except that the samples were analyzed on a
LTQ-Orbitrap XL with 9 MS/MS per MS. The false discovery rate at the protein
identification level was %1% for each analysis, based on a target-decoy
strategy.
Isolation of Synaptosome Fractions and Western Blot
Mice were deeply anesthetized and perfused with 40 ml of Ca2+/Mg2+-free
Dulbecco’s PBS. Brain tissue was removed and synaptosomes were isolated
as previously described (Gray and Whittaker, 1962).
Electrophysiology
Layer V pyramidal neurons were recorded in acute slices as previously
described (Pattwell et al., 2012). All electrophysiological recording experi-
ments were done in double-blind fashion.
In Vivo Transcranial Two-Photon Imaging
Dendritic spines in the mouse motor cortex were imaged with a
two-photon microscope through a thinned-skull window. This procedure
has been described in detail previously (Yang et al., 2009a). All of theCimaging experiments and data analysis were performed in double-blind
fashion.
Behavioral Testing Protocols
Rotarod training, cue-based FC, and NOR behavioral testing were performed
as previously described (Bevins and Besheer, 2006; Lai et al., 2012; Yang
et al., 2009a). All behavioral experiments were performed in double-blind
fashion.
Detailed information on the experimental procedures used can be found in
the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and one table and can be found with this article online at http://dx.
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